STOCK TITAN

Akili to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast on Tuesday, March 7 at 4:30 p.m. ET

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Akili, Inc. (Nasdaq: AKLI) announced a conference call and webcast to discuss its Q4 2022 and full year 2022 financial results on March 7, 2023, at 4:30 p.m. ET. Investors can access the live audio on the company's website. Akili is focused on developing cognitive treatments through digital technologies that engage users via video game experiences, targeting cognitive impairment.

Positive
  • Akili is pioneering cognitive treatments through innovative technology.
  • The company has products validated through clinical trials.
  • Engaging video game experiences are utilized for treatment.
Negative
  • None.

BOSTON--(BUSINESS WIRE)-- Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, will host a conference call and webcast to review its financial and operating results for the fourth quarter and full year of 2022 on Tuesday, March 7, 2023 at 4:30 p.m. ET.

A live audio webcast of the conference call and presentation will be available at www.akiliinteractive.com under Investor Relations, Events & Presentations. An archived version of the webcast will be available on the company’s website following the event.

To access the call, dial 877-407-8029 (toll-free) or 201-689-8029 (international) and reference “Akili Q4 2022 Earnings.” International toll-free numbers are available here.

About Akili

Akili is pioneering the development of cognitive treatments through game-changing technologies. Our approach of leveraging technologies designed to directly target the brain establishes a new category of medicine – medicine that is validated through clinical trials like a drug or medical device but experienced like entertainment. Akili’s platform is powered by proprietary therapeutic engines designed to target cognitive impairment at its source in the brain, informed by decades of research and validated through rigorous clinical programs. Driven by Akili’s belief that effective medicine can also be fun and engaging, Akili’s products are delivered through captivating action video game experiences. For more information, please visit www.akiliinteractive.com.

Santosh Shanbhag

Chief Financial Officer

InvestorRelations@akiliinteractive.com



Julie DiCarlo

SVP, Communications

PR@akiliinteractive.com

Source: Akili, Inc.

FAQ

When is Akili's Q4 2022 earnings call?

Akili's Q4 2022 earnings call is scheduled for March 7, 2023, at 4:30 p.m. ET.

Where can I access the Akili Q4 2022 earnings call?

The earnings call can be accessed on Akili's website under Investor Relations.

What is Akili's stock symbol?

Akili's stock symbol is AKLI.

What new technologies is Akili developing?

Akili is developing cognitive treatments through gaming technologies that engage patients while aiming to improve cognitive impairment.

Akili, Inc.

NASDAQ:AKLI

AKLI Rankings

AKLI Latest News

AKLI Stock Data

34.01M
78.73M
23.21%
61.48%
0.34%
Health Information Services
Surgical & Medical Instruments & Apparatus
Link
United States of America
BOSTON